David Leslie Szekeres - 16 Mar 2026 Form 3 Insider Report for Connect Biopharma Holdings Ltd (CNTB)

Role
President
Signature
/s/ Lisa Peraza attorney-in-fact for David Leslie Szekeres
Issuer symbol
CNTB
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
3
Filing time
16 Mar 2026, 16:47:35 UTC
Previous filing
22 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Szekeres David Leslie President 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO /s/ Lisa Peraza attorney-in-fact for David Leslie Szekeres 16 Mar 2026 0001602459

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTB Ordinary Shares 215,739 16 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 1,772,489 $1.77 Direct F1
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 409,355 $0.9700 Direct F1
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 400,000 $2.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable over four years, with 25% vesting on the first anniversary of the date of grant, and then with respect to the remaining shares on a ratable monthly basis over the next three years, subject to continuous service with the Company as of each applicable vesting date.
F2 The stock option vests and becomes exercisable on a ratable monthly basis over four years, subject to continuous service with the Company as of each applicable vesting date.